Antibiotice SA 2025 IR
The report highlights Antibiotic S.A.'s operational and sustainability performance for the fiscal year 2025. The company achieved total revenues of RON 685.8 million and expanded its product portfolio with 14 new products. On the environmental front, the company increased its share of renewable energy to 27.71% and reduced its total water consumption to 147,164 cubic meters. Additionally, the company committed to the Science Based Targets initiative (SBTi) to set greenhouse gas emission reduction targets aligned with a 1.5°C scenario.
Company: Antibiotice SA
Sector: Health Care
Country: Romania
Year: 2025
Type: IR
Pages: 298
Antibiotice SA
Directors' Report
The report highlights Antibiotic S.A.'s operational and sustainability performance for the fiscal year 2025. The company achieved total revenues of RON 685.8 million and expanded its product portfolio with 14 new products. On the environmental front, the company increased its share of renewable energy to 27.71% and reduced its total water consumption to 147,164 cubic meters. Additionally, the company committed to the Science Based Targets initiative (SBTi) to set greenhouse gas emission reduction targets aligned with a 1.5°C scenario.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees